MedPath

江苏百草堂药业有限公司

Ownership
-
Established
2013-05-27
Employees
-
Market Cap
-
Website
http://www.jsbaicaotang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

云芝糖肽颗粒

Approval Number
国药准字Z20174012
Approval Date
Jun 6, 2022
NMPA

云芝糖肽胶囊

Approval Number
国药准字Z20163011
Approval Date
Jan 14, 2021
NMPA

POSAVERPTIDUM

Product Name
云芝糖肽
Approval Number
国药准字Z10980087
Approval Date
Aug 13, 2020
NMPA

西洋参胶囊

Approval Number
国药准字Z20194106
Approval Date
Sep 17, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.